Table 3.
Number and percentage of participants scoring at or above the cut-off point for depression and anxiety in the treatment (HN001) and placebo groups.
| Univariable odds ratio (95% CI), p-value | Multivariable† odds ratio (95% CI), p-value | |||
|---|---|---|---|---|
| Depression scorea | Depressed N (%) |
Not depressed N (%) |
||
| HN001 | 32 (16.5) | 162 (83.5) | 0.64 (0.39, 1.07) p = 0.086 |
0.65 (0.38, 1.10) p = 0.11 |
| Placebo | 44 (23.5) | 143 (76.5) | Reference | Reference |
| Anxiety scorea | Anxious N (%) |
Not anxious N (%)s |
||
| HN001 | 30 (15.6) | 162 (84.4) | 0.44 (0.27, 0.73) p = 0.001 |
0.44 (0.26, 0.73) p = 0.002 |
| Placebo | 55 (29.4) | 132 (70.6) | Reference | Reference |
a
Three participants had incomplete anxiety data on the STAI6 and one had incomplete depression data on the EPDS, therefore scores could not be calculated.
†
Adjusted for infant colic and time since birth that questionnaires were completed.